BioHealth News

Washington DC’s Vanda Pharmaceuticals’ Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Washington DC’s Vanda Pharmaceuticals’ Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

Read More
Washington D.C.’s 60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

Washington D.C.’s 60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

Read More
Kemp Proteins and Columbia Biosciences Announce Strategic Partnership for Fluorophore Conjugation Solutions

Kemp Proteins and Columbia Biosciences Announce Strategic Partnership for Fluorophore Conjugation Solutions

Read More
MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)

MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)

Read More
Major investments in Maryland’s life sciences sector

Major investments in Maryland’s life sciences sector

Read More
TEDCO Invests in Baltimore Medical Device Company LASARRUS

TEDCO Invests in Baltimore Medical Device Company LASARRUS

Read More
Maryland Life Science Trend Analysis 2024

Maryland Life Science Trend Analysis 2024

Read More
Baltimore’s LaunchPort Welcomes New Resident JuneBrain

Baltimore’s LaunchPort Welcomes New Resident JuneBrain

Read More
BioBuzz Networks and the International Society of Pharmaceutical Engineering – Chesapeake Bay Area Chapter Announce Exciting Partnership

BioBuzz Networks and the International Society of Pharmaceutical Engineering – Chesapeake Bay Area Chapter Announce Exciting Partnership

Read More
NIH cancer physician-scientist Christopher Hourigan joins Virginia Tech to lead research in Washington, D.C.

NIH cancer physician-scientist Christopher Hourigan joins Virginia Tech to lead research in Washington, D.C.

Read More
Surviving and Thriving: John Sackett, Executive Vice President & COO of Adventist Healthcare, and a 67-Year-Old Cystic Fibrosis (CF) Survivor, Offers Perspectives on CF Life Science Innovation with Rich Bendis on BioTalk

Surviving and Thriving: John Sackett, Executive Vice President & COO of Adventist Healthcare, and a 67-Year-Old Cystic Fibrosis (CF) Survivor, Offers Perspectives on CF Life Science Innovation with Rich Bendis on BioTalk

Read More
MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet

MIMETAS to Participate in Holomicrobiome Institute, Backed by €200 Million from Dutch Cabinet

Read More
CNBC – Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart

CNBC – Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart

Read More
AMPEL BioSolutions’ Lupus Test Launches to Predict Flares & Drug Targets

AMPEL BioSolutions’ Lupus Test Launches to Predict Flares & Drug Targets

Read More
Building Baltimore’s Future: Kory Bailey and the UpSurge Vision on BioTalk

Building Baltimore’s Future: Kory Bailey and the UpSurge Vision on BioTalk

Read More
View All Posts